Connect Biopharma (CNTB) Short Interest Ratio & Short Volume $1.86 +0.03 (+1.37%) As of 02:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Connect Biopharma Short Interest DataConnect Biopharma (CNTB) has a short interest of 33,600 shares, representing 0.08% of the float (the number of shares available for trading by the public). This marks a -43.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 113,852 shares to cover all short positions.Current Short Interest33,600 sharesPrevious Short Interest59,900 sharesChange Vs. Previous Month-43.91%Dollar Volume Sold Short$67.87 thousandShort Interest Ratio0.2 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares55,720,000 sharesShort Percent of Float0.08%Today's Trading Volume24,409 sharesAverage Trading Volume113,852 sharesToday's Volume Vs. Average21% Short Selling Connect Biopharma? Sign up to receive the latest short interest report for Connect Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNTB Short Interest Over TimeCNTB Days to Cover Over TimeCNTB Percentage of Float Shorted Over Time Connect Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202533,600 shares $67.87 thousand -43.9%0.1%0.2 $2.02 7/15/202559,900 shares $87.45 thousand +110.9%N/A0.4 $1.46 6/30/202528,400 shares $27.83 thousand +66.1%0.1%0.2 $0.98 6/15/202517,100 shares $16.25 thousand -72.2%0.0%0.1 $0.95 5/31/202561,400 shares $48.00 thousand -19.1%0.1%0.5 $0.78 5/15/202575,900 shares $55.18 thousand +56.5%0.2%0.7 $0.73 4/30/202548,500 shares $39.85 thousand -25.4%N/A0.5 $0.82 4/15/202565,000 shares $53.94 thousand +1,103.7%0.2%0.7 $0.83 3/31/20255,400 shares $2.97 thousand -47.6%0.0%0.1 $0.55 3/15/202510,300 shares $8.82 thousand -77.9%0.0%0.5 $0.86 Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/28/202546,700 shares $42.17 thousand +56.7%0.1%1.9 $0.90 2/15/202529,800 shares $27.49 thousand -4.8%0.1%1.2 $0.92 1/31/202531,300 shares $30.42 thousand -23.5%0.1%1.1 $0.97 1/15/202540,900 shares $42.95 thousand -44.6%0.1%1.5 $1.05 12/31/202473,800 shares $101.84 thousand -16.0%0.1%2.6 $1.38 12/15/202487,800 shares $98.20 thousand +53.5%0.2%3.1 $1.12 11/30/202457,200 shares $60.63 thousand -7.4%0.1%2.2 $1.06 11/15/202461,800 shares $68.60 thousand +110.2%0.1%2.1 $1.11 10/31/202429,400 shares $34.10 thousand -35.4%0.1%1 $1.16 10/15/202445,500 shares $57.33 thousand +26.7%0.1%1.7 $1.26 9/30/202435,900 shares $50.98 thousand +60.3%0.1%1.2 $1.42 9/15/202422,400 shares $27.55 thousand +5.2%0.0%0.5 $1.23 8/31/202421,300 shares $34.08 thousand +76.0%0.0%0.4 $1.60 8/15/202412,100 shares $13.79 thousand -9.7%0.0%0.2 $1.14 7/31/202413,400 shares $15.95 thousand +24.1%0.0%0.2 $1.19 7/15/202410,800 shares $13.61 thousand -30.3%0.0%0.2 $1.26 6/30/202415,500 shares $23.56 thousand -44.2%0.0%0.2 $1.52 6/15/202427,800 shares $44.48 thousand -21.5%0.1%0.2 $1.60 5/31/202435,400 shares $60.53 thousand -34.6%0.1%0.3 $1.71 5/15/202454,100 shares $99.00 thousand +73.4%0.1%0.3 $1.83 4/30/202431,200 shares $43.37 thousand -62.5%0.1%0.2 $1.39 4/15/202483,100 shares $138.78 thousand -28.1%0.2%0.5 $1.67 3/31/2024115,500 shares $200.97 thousand +7.5%0.2%0.7 $1.74 3/15/2024107,400 shares $139.62 thousand -13.2%0.2%0.8 $1.30 2/29/2024123,700 shares $141.02 thousand -2.7%0.2%0.4 $1.14 2/15/2024127,100 shares $153.79 thousand -34.8%0.2%0.4 $1.21 1/31/2024194,800 shares $227.92 thousand +52.8%0.4%0.5 $1.17 1/15/2024127,500 shares $140.86 thousand -21.3%0.2%0.3 $1.10 12/31/2023162,100 shares $191.28 thousand -59.8%0.3%0.4 $1.18 12/15/2023403,200 shares $380.54 thousand +208.3%0.8%1.1 $0.94BREAKING: The House just passed 3 pro-crypto bills! (Ad)THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result. 11/30/2023130,800 shares $150.42 thousand +476.2%0.3%0.6 $1.15 11/15/202322,700 shares $40.41 thousand -22.8%0.0%0.1 $1.78 10/31/202329,400 shares $43.22 thousand +88.5%0.1%0.5 $1.47 10/15/202315,600 shares $13.54 thousand -40.7%0.0%0.3 $0.87 9/30/202326,300 shares $21.54 thousand +250.7%0.1%0.6 $0.82 9/15/20237,500 shares $5.70 thousand -13.8%0.0%0.2 $0.76 8/31/20238,700 shares $7.18 thousand -61.5%0.0%0.2 $0.83 8/15/202322,600 shares $20.36 thousand -48.3%0.0%0.1 $0.90 7/31/202343,700 shares $42.39 thousand +55.5%0.1%0.1 $0.97 7/15/202328,100 shares $30.35 thousand -52.5%0.1%0.1 $1.08 6/30/202359,200 shares $66.90 thousand -19.8%0.1%0.2 $1.13 6/15/202373,800 shares $74.54 thousand -12.3%0.1%0.2 $1.01 5/31/202384,100 shares $91.15 thousand +14.3%0.2%0.1 $1.08 5/15/202373,600 shares $91.26 thousand -23.1%0.1%0.2 $1.24 4/30/202395,700 shares $101.92 thousand -25.8%0.2%0.3 $1.07 4/15/2023128,900 shares $135.35 thousand -14.1%0.2%0.4 $1.05 3/31/2023150,000 shares $149.99 thousand +100.8%0.3%0.5 $1.00 3/15/202374,700 shares $83.66 thousand -12.2%0.1%0.2 $1.12 2/28/202385,100 shares $109.78 thousand -15.0%0.2%1.6 $1.29 2/15/2023100,100 shares $103.10 thousand -11.0%0.2%2 $1.03 1/31/2023112,500 shares $138.38 thousand -3.5%0.2%2.3 $1.23 1/15/2023116,600 shares $115.32 thousand -12.5%0.2%2.3 $0.99 12/30/2022133,200 shares $115.59 thousand -58.0%0.3%2.4 $0.87 12/15/2022316,800 shares $275.62 thousand -1.2%0.6%2.8 $0.87 11/30/2022320,600 shares $232.53 thousand -4.0%0.6%2.8 $0.73 11/15/2022334,000 shares $251.20 thousand -8.2%0.6%2.5 $0.75 10/31/2022364,000 shares $316.61 thousand -32.0%0.7%2.1 $0.87 10/15/2022535,000 shares $506.00 thousand +29.9%1.0%1.7 $0.95 9/30/2022411,900 shares $531.35 thousand +2.6%0.8%1.3 $1.29 9/15/2022401,400 shares $586.04 thousand -15.7%0.8%1.1 $1.46 8/31/2022476,400 shares $666.96 thousand -2.2%0.9%1.2 $1.40 8/15/2022487,100 shares $706.30 thousand +1.1%0.9%1.2 $1.45 7/31/2022481,600 shares $392.60 thousand +7.6%0.9%1.1 $0.82 7/15/2022447,600 shares $407.32 thousand +124.8%0.8%1.1 $0.91 6/30/2022199,100 shares $173.22 thousand +7.4%0.4%0.5 $0.87 6/15/2022185,400 shares $133.99 thousand -18.0%0.4%0.7 $0.72 5/31/2022226,000 shares $180.80 thousand +23.4%N/A0.9 $0.80 5/15/2022183,100 shares $137.33 thousand -42.5%N/A0.7 $0.75 4/30/2022318,400 shares $646.35 thousand +5.5%N/A1.7 $2.03 4/15/2022301,900 shares $863.43 thousand +6.0%N/A3.5 $2.86 3/31/2022284,900 shares $860.40 thousand +8.6%N/A2.3 $3.02 3/15/2022262,400 shares $645.50 thousand +2.3%N/A1.1 $2.46 2/28/2022256,500 shares $1.01 million +7.1%N/A0.9 $3.92 2/15/2022239,600 shares $1.08 million -24.3%N/A0.7 $4.50 1/31/2022316,600 shares $1.46 million -7.5%0.6%0.7 $4.60 1/15/2022342,400 shares $1.76 million +25.7%N/A0.7 $5.14 12/31/2021272,400 shares $1.40 million +3.6%N/A0.6 $5.15 12/15/2021263,000 shares $1.22 million +533.7%N/A0.8 $4.64 11/30/202141,500 shares $180.53 thousand -97.7%N/A0.1 $4.35 11/15/20211,810,000 shares $23.57 million +30.2%N/A7.4 $13.02BREAKING: The House just passed 3 pro-crypto bills! (Ad)THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result. 10/29/20211,390,000 shares $22.02 million +36.3%N/A15.3 $15.84 10/15/20211,020,000 shares $17.51 million +19.3%N/A13.9 $17.17 9/30/2021855,200 shares $20.72 million +0.1%N/A15.6 $24.23 9/15/2021854,600 shares $18.23 million +0.3%N/A14.2 $21.33 8/31/2021851,700 shares $19.99 million +0.6%N/A13.6 $23.47 8/13/2021846,300 shares $19.90 million No ChangeN/A14.1 $23.51 CNTB Short Interest - Frequently Asked Questions What is Connect Biopharma's current short interest? Short interest is the volume of Connect Biopharma shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 33,600 shares of CNTB short. 0.08% of Connect Biopharma's shares are currently sold short. Learn More on Connect Biopharma's current short interest. What is a good short interest percentage for Connect Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Connect Biopharma's floating shares are currently sold short. Is Connect Biopharma's short interest increasing or decreasing? Connect Biopharma saw a drop in short interest in the month of July. As of July 31st, there was short interest totaling 33,600 shares, a drop of 43.9% from the previous total of 59,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Connect Biopharma's short interest compare to its competitors? 0.08% of Connect Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Connect Biopharma: Esperion Therapeutics, Inc. (11.95%), Nanobiotix S.A. Sponsored ADR (0.04%), Aquestive Therapeutics, Inc. (10.37%), Replimune Group, Inc. (28.80%), I-Mab Sponsored ADR (0.80%), Aura Biosciences, Inc. (5.93%), Kamada Ltd. (0.15%), COMPASS Pathways PLC Sponsored ADR (9.16%), Compass Therapeutics, Inc. (9.22%), Corvus Pharmaceuticals, Inc. (16.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Connect Biopharma stock? Short selling CNTB is an investing strategy that aims to generate trading profit from Connect Biopharma as its price is falling. CNTB shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Connect Biopharma? A short squeeze for Connect Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTB, which in turn drives the price of the stock up even further. How often is Connect Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTB, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies ESPR Short Interest NBTX Short Interest AQST Short Interest REPL Short Interest IMAB Short Interest AURA Short Interest KMDA Short Interest CMPS Short Interest CMPX Short Interest CRVS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNTB) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access